Skip to main content

Table 1 Numbers (%) of drugs for mood stabilizers, antipsychotics, antidepressants and BZRAs divided by age and sex

From: Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study

 

Sex

Age (years)

Males

Females

Significance

 ≤ 39

40–64

 ≥ 65

Significance

N = 1408

N = 1698

N = 676

N = 1899

N = 531

Mood stabilizers

 Lithium

718 (51.0%)

755 (44.5%)

 < 0.001

287 (42.5%)

902 (47.5%)

284 (53.5%)

 < 0.001

 Valproate

408 (29.0%)

474 (27.9%)

0.513

160 (23.7%)

575 (30.3%)

147 (27.7%)

0.004

 Lamotrigine

337 (23.9%)

397 (23.4%)

0.717

200 (29.6%)

465 (24.5%)

69 (13.0%)

 < 0.001

 Carbamazepine

72 (5.1%)

77 (4.5%)

0.452

21 (3.1%)

103 (5.4%)

25 (4.7%)

0.053

Other medications

 Antipsychotics

777 (55.1%)

911 (53.6%)

0.393

387 (57.2%)

1075 (56.6%)

226 (42.5%)

 < 0.001

 Antidepressants

566 (40.1%)

713 (41.9%)

0.312

271 (40.0%)

822 (43.2%)

186 (35.0%)

0.002

 BZRAs

969 (68.8%)

1236 (72.7%)

0.015

443 (65.5%)

1391 (73.2%)

371 (69.8%)

 < 0.001

  1. BZRAs, benzodiazepine receptor agonists